Literature DB >> 34506942

Systemic inhibition or global deletion of CaMKK2 protects against post-traumatic osteoarthritis.

E Mével1, J A Shutter2, X Ding3, B T Mattingly4, J N Williams5, Y Li6, A Huls7, A V Kambrath8, S B Trippel9, D Wagner10, M R Allen11, R O'Keefe12, W R Thompson13, D B Burr14, U Sankar15.   

Abstract

OBJECTIVE: To investigate the role of Ca2+/calmodulin-dependent protein kinase 2 (CaMKK2) in post-traumatic osteoarthritis (PTOA).
METHODS: Destabilization of the medial meniscus (DMM) or sham surgeries were performed on 10-week-old male wild-type (WT) and Camkk2-/- mice. Half of the DMM-WT mice and all other cohorts (n = 6/group) received tri-weekly intraperitoneal (i.p.) injections of saline whereas the remaining DMM-WT mice (n = 6/group) received i.p. injections of the CaMKK2 inhibitor STO-609 (0.033 mg/kg body weight) thrice a week. Study was terminated at 8- or 12-weeks post-surgery, and knee joints processed for microcomputed tomography imaging followed by histology and immunohistochemistry. Primary articular chondrocytes were isolated from knee joints of 4-6-day-old WT and Camkk2-/- mice, and treated with 10 ng/ml interleukin-1β (IL)-1β for 24 or 48 h to investigate gene and protein expression.
RESULTS: CaMKK2 levels and activity became elevated in articular chondrocytes following IL-1β treatment or DMM surgery. Inhibition or absence of CaMKK2 protected against DMM-associated destruction of the cartilage, subchondral bone alterations and synovial inflammation. When challenged with IL-1β, chondrocytes lacking CaMKK2 displayed attenuated inflammation, cartilage catabolism, and resistance to suppression of matrix synthesis. IL-1β-treated CaMKK2-null chondrocytes displayed decreased IL-6 production, activation of signal transducer and activator of transcription 3 (Stat3) and matrix metalloproteinase 13 (MMP13), indicating a potential mechanism for the regulation of inflammatory responses in chondrocytes by CaMKK2.
CONCLUSIONS: Our findings reveal a novel function for CaMKK2 in chondrocytes and highlight the potential for its inhibition as an innovative therapeutic strategy in the prevention of PTOA.
Copyright © 2021 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenosine monophosphate dependent protein kinase (AMPK); Articular chondrocytes; Ca(2+/)calmodulin-dependent protein kinase kinase 2 (CaMKK2); Destabilization of medial meniscus (DMM); IL-6; Interleukin-1β (IL-1β); Osteoarthritis; Signal transducer and activator of transcription 3 (Stat3)

Mesh:

Substances:

Year:  2021        PMID: 34506942      PMCID: PMC8712369          DOI: 10.1016/j.joca.2021.09.001

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  57 in total

1.  Differential regulatory mechanism of Ca2+/calmodulin-dependent protein kinase kinase isoforms.

Authors:  H Tokumitsu; M Iwabu; Y Ishikawa; R Kobayashi
Journal:  Biochemistry       Date:  2001-11-20       Impact factor: 3.162

2.  JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of Type II collagen, aggrecan core, and link protein transcription in articular chondrocytes. Association with a down-regulation of SOX9 expression.

Authors:  Florence Legendre; Jayesh Dudhia; Jean-Pierre Pujol; Patrick Bogdanowicz
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

Review 3.  Macrophages regulate the progression of osteoarthritis.

Authors:  H Zhang; D Cai; X Bai
Journal:  Osteoarthritis Cartilage       Date:  2020-01-23       Impact factor: 6.576

4.  The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse.

Authors:  S S Glasson; M G Chambers; W B Van Den Berg; C B Little
Journal:  Osteoarthritis Cartilage       Date:  2010-10       Impact factor: 6.576

5.  STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase.

Authors:  Hiroshi Tokumitsu; Hiroyuki Inuzuka; Yumi Ishikawa; Masahiko Ikeda; Ikutaro Saji; Ryoji Kobayashi
Journal:  J Biol Chem       Date:  2002-02-26       Impact factor: 5.157

Review 6.  The Ca(2+)/Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft.

Authors:  Kathrina L Marcelo; Anthony R Means; Brian York
Journal:  Trends Endocrinol Metab       Date:  2016-07-20       Impact factor: 12.015

Review 7.  Osteoarthritis.

Authors:  Mary B Goldring; Steven R Goldring
Journal:  J Cell Physiol       Date:  2007-12       Impact factor: 6.384

Review 8.  The Year in Basic Science: calmodulin kinase cascades.

Authors:  Anthony R Means
Journal:  Mol Endocrinol       Date:  2008-10-09

9.  Inhibition of CaMKK2 Enhances Fracture Healing by Stimulating Indian Hedgehog Signaling and Accelerating Endochondral Ossification.

Authors:  Justin N Williams; Anuradha Valiya Kambrath; Roshni B Patel; Kyung Shin Kang; Elsa Mével; Yong Li; Ying-Hua Cheng; Austin J Pucylowski; Mariah A Hassert; Michael J Voor; Melissa A Kacena; William R Thompson; Stuart J Warden; David B Burr; Matthew R Allen; Alexander G Robling; Uma Sankar
Journal:  J Bone Miner Res       Date:  2018-02-05       Impact factor: 6.390

Review 10.  mTOR: a potential therapeutic target in osteoarthritis?

Authors:  Bandna Pal; Helal Endisha; Yue Zhang; Mohit Kapoor
Journal:  Drugs R D       Date:  2015-03
View more
  1 in total

1.  Exosomes derived from platelet-rich plasma administration in site mediate cartilage protection in subtalar osteoarthritis.

Authors:  Yu Zhang; Xiaowei Wang; Jian Chen; Dingfei Qian; Peng Gao; Tao Qin; Tao Jiang; Jiang Yi; Tao Xu; Yifan Huang; Qian Wang; Zheng Zhou; Tianyi Bao; Xuan Zhao; Hao Liu; Ziyang Zheng; Jin Fan; Shujie Zhao; Qingqing Li; Guoyong Yin
Journal:  J Nanobiotechnology       Date:  2022-01-29       Impact factor: 10.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.